2016 Networking Patients Side effects 
European Pharmaceutical Review
JULY 5, 2022
The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. New hope for stomach cancer patients.
European Pharmaceutical Review
DECEMBER 14, 2023
Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. They also include many of the common “exclusions” in RCTs, such as pregnant women, children, the elderly and patients on multiple medications. Meta-analyses contributed least frequently (31.4 As of October 2023, 62.93
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 20, 2022
Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. This is usually on a much larger scale than is possible in clinical trials and can uncover less common side effects. Supporting regulators. Study focus. almitrine – a respiratory stimulant.
European Pharmaceutical Review
SEPTEMBER 22, 2023
Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5
Pharmaceutical Technology
JUNE 20, 2023
Thematic Research [ii] shows that adoption of EMR systems is very high, especially in the US, and CDS systems are leveraging AI technology and available EMRs to provide clinical insight to both physicians and patients. Neural networks learn to “translate” from language A to language B.
Expert insights. Personalized for you.
81 
Let's personalize your content